丹麦或日本BCG与俄罗斯BCG早期接种健康新生儿:随机对照试验
在几内亚比绍国家医院开展的平行组开放标签随机对照试验,健康新生儿分别接种BCG-Denmark与BCG-Russia,中期后改为BCG-Japan与BCG-Russia比较。6周时住院率与死亡率在菌株间无差异,但BCG-Denmark和BCG-Japan诱导更多卡疤和PPD反应。
要点
- BCG菌株对6周发病率无显著影响
- 丹麦和日本BCG免疫原性高于俄罗斯BCG
- 菌株差异对结核保护及总体健康的影响待进一步研究
核心结论
- BCG菌株不影响发病率,但丹麦和日本BCG比俄罗斯BCG更具免疫原性。
研究设计与样本
- 平行组、开放标签随机对照试验,在几内亚比绍国家医院开展。
- 健康新生儿1:1随机接种BCG-Denmark(随机2851例,分析2840例)或BCG-Russia(随机2845例,分析2837例)。
- 试验中期BCG-Denmark停产,继续比较BCG-Japan(随机3191例,分析3184例)与BCG-Russia(随机3170例,分析3160例)。
- 通过电话、家访和国家医院收集死亡与发病数据,采用Cox模型评估6周死亡率比(MRR)和住院发生率比(IRR)。
主要发现
- BCG-Denmark和BCG-Japan诱导的卡疤和PPD反应多于BCG-Russia。
临床怎么用
- 不同BCG菌株在6周发病率和死亡率上未见差异,传统免疫原性指标(卡疤、PPD反应)丹麦和日本菌株优于俄罗斯菌株。
- 菌株差异对结核保护及总体健康的影响需进一步研究,临床选择应结合当地供应与指南。
局限性
- 开放标签设计可能引入偏倚。
- 随访仅至6周,长期结局未报告。
- BCG-Denmark中途停产导致试验方案调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bacille Calmette-Guérin (BCG) vaccination remains a cornerstone against tuberculosis. Randomized controlled trials (RCTs) have demonstrated that BCG-Denmark lowers all-cause mortality, but a recent RCT found no effect of BCG-Russia. Observational studies indicate that the genetically divergent BCG strains have different effects. METHODS: This was a parallel-group, open-label RCT conducted at the National Hospital in Guinea-Bissau. Healthy neonates were randomized 1:1 to BCG-Denmark (2851 randomized, 2840 analyzed) vs BCG-Russia (2845 randomized, 2837 analyzed). We hypothesized that BCG-Denmark would reduce morbidity (primary outcome) and mortality while inducing more BCG reactions and purified protein derivative (PPD) responses (secondary outcomes). Halfway through the trial, production of BCG-Denmark was halted, and the trial continued comparing BCG-Japan (3191 neonates randomized, 3184 analyzed) with BCG-Russia (3170 randomized, 3160 analyzed). Mortality and morbidity data were collected by telephone, at home visits, and at the National Hospital and assessed in Cox models providing 6-week mortality rate ratios (MRRs) and hospitalization incidence rate ratios (IRRs). RESULTS: By age 6 weeks, there were 140 and 130 admissions among neonates vaccinated with BCG-Denmark and BCG-Russia, respectively (IRR, 1.08 [95% confidence interval {CI}, .84-1.37]). For BCG-Japan, there were 185 admissions vs 161 admissions for BCG-Russia (IRR, 1.15 [95% CI, .93-1.43]). The 6-week mortality did not differ: BCG-Denmark/BCG-Russia (MRR, 1.15 [95% CI, .74-1.80]); BCG-Japan/BCG-Russia (MRR, 0.71 [95% CI, .43-1.19]). BCG-Denmark and BCG-Japan induced more BCG scars and PPD reactions than BCG-Russia. CONCLUSIONS: BCG strains did not affect morbidity. BCG-Denmark and BCG-Japan were more immunogenic than BCG-Russia by the measures traditionally viewed as surrogates for successful immunization. The implications of strain differences for tuberculosis protection and overall health warrant further study. CLINICAL TRIALS REGISTRATION: NCT02447536.
引用
- Schaltz-Buchholzer F, Bjerregaard-Andersen M, Øland CB, et al. Early Vaccination With Bacille Calmette-Guérin-Denmark or BCG-Japan Versus BCG-Russia to Healthy Newborns in Guinea-Bissau: A Randomized Controlled Trial. Clin Infect Dis. 2020. PMID: 31677386. doi:10.1093/cid/ciz1080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。